G. Pierchalla

发表

Chemokine Expression-Based Endotype Clustering of Chronic Rhinosinusitis

T. Zuberbier, C. Bachert, M. Artuc, 2022, Journal of personalized medicine.

Omalizumab in patients with NSAIDs-exacerbated respiratory disease.

K. Bergmann, H. Olze, G. Pierchalla, 2020, Rhinology.

Analysis of genetic impact on smell impairment in patients with hereditary angioedema type 1 and 2

S. Cichon, M. Nöthen, S. Heilmann-Heimbach, 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].

H. Olze, U. Förster-Ruhrmann, A. Szczepek, 2019, HNO.